Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent years have seen a rapid increase in the use of gut microbiota-targeting interventions, such as probiotics, for the treatment of psychiatric disorders. The objective of this update review was to evaluate all randomised controlled clinical trial evidence on the efficacy of probiotics for clinical depression. Cochrane guidelines for updated reviews were followed. By searching PubMed and Web of Science databases, we identified 546 new records since our previous review. A total of seven studies met selection criteria, capturing 404 people with depression. A random effects meta-analysis using treatment type (stand-alone vs. adjunctive) as subgroup was performed. The results demonstrated that probiotics are effective in reducing depressive symptoms when administered in addition to antidepressants (SMD = 0.83, 95%CI 0.49–1.17), however, they do not seem to offer significant benefits when used as stand-alone treatment (SMD = −0.02, 95%CI −0.34–0.30). Potential mechanisms of action may be via increases in brain-derived neurotrophic factor (BDNF) and decreases in C-reactive protein (CRP), although limited evidence is available at present. This review offers stronger evidence to support the clinical use of probiotics in depressed populations and provides an insight into the mode of administration more likely to yield antidepressant effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study flow diagram for updated reviews. Adapted from Stovold et al. [25].](https://figures.cochat.ai/paper-figures/270ca885976b49c79212cf3fee4c2f7c/updated-review-and-meta-analysis-of-probiotics-for-the-treatment-of-clinical-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Probiotics have been recently tested to re-establish a healthy microbial status, due to their ability to balance the dysbiosis created under the depressive state [117].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“Due to the low number of studies, and in accordance with published recommendations [24], we did not perform additional sensitivity analyses, meta-regression, or assessment of publication bias.”
ResultMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · cited 2×
“Multiple animal and healthy volunteer studies have demonstrated that probiotics and the gut microbiota can alter circulating levels of pro-inflammatory and anti-inflammatory cytokines [13].”
BackgroundOtte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 1×
“For example, a recent study in rats found that the NMDA receptor antagonist ketamine amplifies levels of the genus Lactobacilli [44], which has been found to be reduced in depressed animals, with some evidence of decreases in clinical populations as well [45,46].”
BackgroundThe neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963
Research works printed but not linked: 1
- Cumpston M. Changler J. Chapter IV: Updating a review Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 updated September 2020 Cochrane London, UK Available online: https://training.cochrane.org/handbook/current/chapter-iv (accessed on 17 December 2020)
Cited by
Schaub, A.-C., Schneider, E., Vazquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01977-z · Cited by 242
“However, another recent meta-analysis [18] indicate that probiotics are effective in reducing depressive symptoms when administered in addition to antidepressants but not when used as stand-alone treatment.”
ResultChen, L.-M., Bao, C.-H., Wu, Y., Liang, S.-H., Wang, D., Wu, L.-Y., Huang, Y., Liu, H.-R., & Wu, H.-G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02175-2 · Cited by 227
“Probiotics can be used to assist in the treatment of depression [135].”
BackgroundYin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 179
Nikolova, V. L., Cleare, A. J., Young, A. H., & Stone, J. M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1817 · Cited by 140
Self-citationJohnson, D., Thurairajasingam, S., Letchumanan, V., Chan, K., & Lee, L. (2021) · Nutrients · doi:10.3390/nu13051728 · Cited by 139
“Although most of pre-clinical studies and some clinical studies have demonstrated the efficacy of probiotics as a stand-alone treatment in depressive disorders, one of the recent meta-analyses of probiotic intervention in clinical depression concluded that probiotics are best used as an adjunct to antidepressants rath…”
MethodResultSchneider, E., Doll, J. P. K., Schweinfurth, N., Kettelhack, C., Schaub, A.-C., Yamanbaeva, G., Varghese, N., Mählmann, L., Brand, S., Eckert, A., et al. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220117 · Cited by 97
“Nevertheless, the direction of the BDNF change is congruent to the findings of other studies reporting significantly increased BDNF levels when probiotics were given in addition to antidepressant treatment, 54 but not given as stand-alone treatment.”
BackgroundResultThe gut microbiota and depressive symptoms across ethnic groups
Bosch, J. A., Nieuwdorp, M., Zwinderman, A. H., Deschasaux, M., Radjabzadeh, D., Kraaij, R., Davids, M., de Rooij, S. R., & Lok, A. (2022) · Nature Communications · doi:10.1038/s41467-022-34504-1 · Cited by 120
Ribera, C., Sánchez‐Ortí, J. V., Clarke, G. A., Marx, W., Mörkl, S., & Balanzá‐Martínez, V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105561 · Cited by 100
“In fact, as other previous meta-analysis have pointed out, antidepressants might have antimicrobial effect and may interact with probiotics (Chait et al., 2020; Nikolova et al., 2021).”
Probiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 87
“Probiotics exhibit antidepressant properties in the absence of other therapeutic options (Nikolova et al., 2021).”
BackgroundThe Role of Probiotics and Their Metabolites in the Treatment of Depression
Jach, M. E., Serefko, A., Szopa, A., Sajnaga, E., Golczyk, H., Santos, L. S., Borowicz, K. K., & Sieniawska, E. (2023) · Molecules · doi:10.3390/molecules28073213 · Cited by 89
Microbiota-targeted interventions for mental health
Berding, K., & Cryan, J. F. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000758 · Cited by 76
Sultan, S., Mottawea, W., Yeo, J., & Hammami, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313166 · Cited by 72
Johnson, D., Letchumanan, V., Thum, C. C., Thurairajasingam, S., & Lee, L. (2023) · Nutrients · doi:10.3390/nu15061382 · Cited by 78
“remain an ideal option for their significant anti-depressive potential [20,26].”
BackgroundMusazadeh, V., Zarezadeh, M., Faghfouri, A. H., Keramati, M., Jamilian, P., Jamilian, P., Mohagheghi, A., & Farnam, A. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2051164 · Cited by 68
“…2016 to 2021, and two studies were conducted in China (Huang, Wang, and Hu 2016, Chao et al. 2020), two in the United Kingdom (Nikolova et al. 2019, Nikolova et al. 2021), one in Iran (Amirani et al. 2020), one in the United States (Liu, Walsh, and Sheehan 2019), one in Japan (Sanada et al. 2020),…”
BackgroundAntimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54
Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome
Brushett, S., Gaćeša, R., Vila, A. V., Gois, M. F. B., Andreu‐Sánchez, S., Swarte, J. C., Klaassen, M. A. Y., Collij, V., Sinha, T., Bolte, L. A., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2281360 · Cited by 59
Morales-Torres, R., Carrasco-Gubernatis, C., Grasso-Cladera, A., Cosmelli, D., Parada, F. J., & Palacios-García, I. (2023) · Nutrients · doi:10.3390/nu15071706 · Cited by 44
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
BackgroundSlykerman, R. F., Davies, N., Vlčková, K., O’Riordan, K. J., Bassett, S. A., Dekker, J., Schellekens, H., Hyland, N. P., Clarke, G. A., & Patterson, E. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70079 · Cited by 50
Nikolova, V. L., Pelton, L., Moulton, C. D., Zorzato, D., Cleare, A. J., Young, A. H., & Stone, J. M. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001046 · Cited by 40
“Likewise, dietary interventions have been found to impact positively on affective disorders, and there is accumulating evidence from randomized controlled trials that depression, anxiety, and bipolar disorder can be improved by probiotic therapies (28,29,72) and even by fecal microbial transplantation (73).”
BackgroundSelf-citationStress, inflammation, microbiome and depression
Medina-Rodriguez, E. M., Cruz, A. A., Abreu, J. C. D., & Beurel, E. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173561 · Cited by 46
The gut–brain–circadian axis in anxiety and depression: a critical review
Bautista, J., Hidalgo‐Tinoco, C., Delgado, M. D. C., Viteri-Recalde, J., Guerra-Guerrero, A., & López‐Cortés, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1697200 · Cited by 47
IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 42
Misera, A., Liśkiewicz, P., Łoniewski, I., Skonieczna-Żydecka, K., & Samochowiec, J. (2021) · Pharmaceuticals · doi:10.3390/ph14100952 · Cited by 34
Sempach, L., Doll, J. P. K., Limbach, V., Marzetta, F., Schaub, A.-C., Schneider, E., Kettelhack, C., Mählmann, L., Schweinfurth, N., Ibberson, M. R., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03030-7 · Cited by 37
Zhao, S., Liang, S., Tao, J., Ye, P., Chen, S., Wai, H. K.-F., Chung, F.-Y., Sin, Z. Y., Wong, M. K. L., Haqq, A. M., et al. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuad171 · Cited by 34
Misera, A., Łoniewski, I., Palma, J., Kulaszyńska, M., Czarnecka, W., Kaczmarczyk, M., Liśkiewicz, P., Samochowiec, J., & Skonieczna‐Żydecka, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125022 · Cited by 30
PRO-DEMET Randomized Controlled Trial on Probiotics in Depression—Pilot Study Results
Gawlik-Kotelnicka, O., Margulska, A., Skowrońska, A., & Strzelecki, D. (2023) · Nutrients · doi:10.3390/nu15061400 · Cited by 27
Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review
Brown, L. C., Bobo, W. V., Gall, C. A., Müller, D. J., & Bousman, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071086 · Cited by 27
Dietary intervention in depression – a review
Wu, T., Liu, R., Zhang, L., Rifky, M., Sui, W., Zhu, Q., Zhang, J., Yin, J., & Zhang, M. (2022) · Food & Function · doi:10.1039/d2fo02795j · Cited by 25
Green, J. E., McGuinness, A. J., Berk, M., Castle, D. J., Athan, E., Hair, C., Strandwitz, P., Loughman, A., Nierenberg, A. A., Cryan, J. F., et al. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01235-z · Cited by 23
“Meta-analyses of studies investigating probiotic supplementation as an adjunctive treatment for depression suggest that this treatment strategy may be effective for the reduction of depressive symptoms, particularly in those with clinical depression [14, 15], or alongside antidepressant therapy [16].”
BackgroundThe Gut Microbiome in Anxiety Disorders
Butler, M., Kittel‐Schneider, S., Wagner‐Skacel, J., Mörkl, S., & Clarke, G. A. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01604-w · Cited by 24
“There is reasonably robust evidence for using specific adjunctive probiotics in patients with MDD [56, 83, 84].”
Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome
Tanaka, Y., Shimizu, S., Shirotani, M., Yorozu, K., Kitamura, K., Oehorumu, M., Kawai, Y., & Fukuzawa, Y. (2021) · Nutrients · doi:10.3390/nu13103326 · Cited by 23
Chait, Y. A., Mottawea, W., Tompkins, T. A., & Hammami, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087326 · Cited by 22
Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
Gawlik-Kotelnicka, O., & Strzelecki, D. (2021) · Pharmaceuticals · doi:10.3390/ph14040384 · Cited by 20
“Nikolova et al 2021 [78] 7 RCTs 404 subjects Reduced the depression scale score by 0.”
BackgroundMethodHan, W., Wang, N., Han, M., Ban, M., Sun, T., & Xu, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1029495 · Cited by 21
“Recent meta-analyses and systematic reviews have confirmed the antidepressant efficacy of probiotics in clinical studies (Amirani et al., 2020; Nikolova et al., 2021).”
ResultHe, J., Chang, L., Zhang, L., Wu, W., & Zhuo, D. (2023) · Medicine · doi:10.1097/md.0000000000036005 · Cited by 19
“33] However, the temporal longevity of such positive effects remains elusive, and the influence of intervention duration on sustained probiotic benefits warrants further investigation.”
BackgroundGawlik-Kotelnicka, O., Skowrońska, A., Margulska, A., Czarnecka, K. H., Łoniewski, I., Skonieczna‐Żydecka, K., & Strzelecki, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071342 · Cited by 20
“The results of the most recent meta-analysis on the use of probiotics in clinical depression demonstrated that probiotics are effective in reducing depressive symptoms when administered as an add-on; however, they do not seem to offer significant benefits when used as stand-alone treatment [36].”
ResultThe Microbiome and Mental Health Across the Lifespan
Dickerson, F., Dilmore, A. H., Godoy‐Vitorino, F., Nguyen, T. T., Paulus, M. P., Pinto‐Tomás, A. A., Moya-Roman, C., Zúñiga-Chaves, I., Severance, E. G., & Jeste, D. V. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_384 · Cited by 18
Palacios‐García, I., Mhuireach, G. A., Grasso‐Cladera, A., Cryan, J. F., & Parada, F. J. (2022) · BioEssays · doi:10.1002/bies.202100249 · Cited by 14
MACREA, C. M., Ilias, T. I., Frățilă, O., Brata, R. D., & Hocopan, C. (2023) · Biomedical Papers · doi:10.5507/bp.2023.024 · Cited by 14
Reproducible microbiome composition signatures of anxiety and depressive symptoms
Kouraki, A., Kelly, A., Vijay, A., Gohir, S. A., Astbury, S., Georgopoulos, V., Millar, B., Walsh, D. A., Ferguson, E., Menni, C., et al. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.035 · Cited by 14
“Another meta-analysis failed to find an association with depression [83].”
BackgroundBaseline gut microbiota profiles affect treatment response in patients with depression
Xie, Y., Zhu, H., Yuan, Y., Guan, X., Xie, Q., & Dong, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1429116 · Cited by 17
Probiotics/prebiotics/synbiotics and human neuropsychiatric outcomes: an umbrella review
Du, Q., Li, Q., Liu, C., Liao, G., Li, J., Yang, J., Zhang, Q., Gong, X., & Li, K. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00035 · Cited by 21
Menni, A.-E., Theodorou, H., Tzikos, G., Theodorou, I. M., Semertzidou, E., Stelmach, V., Shrewsbury, A. D., Stavrou, G., & Kotzampassi, K. E. (2025) · Nutrients · doi:10.3390/nu17122022 · Cited by 14
Probiotics as a Complementary Medicine in Neurologic Disorders
Jafari, M., Alipour, M., Zamani, S., Amiri, A. M., Pourabbas, P., & Bibalan, M. H. (2025) · Health Science Reports · doi:10.1002/hsr2.71422 · Cited by 15
“…the evidence supports their role as low ‐ risk complementary strategies that may optimize treatment outcomes when integrated with standard care, particularly in patients seeking multimodal therapeutic approaches or experiencing suboptimal responses to conventional treatments alone [44, 45].”
Wang, Z., Wang, X., Zhao, X., Hu, Z., Sun, D., Wu, D., & Xing, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970933 · Cited by 10
Skowrońska, A., Gawlik-Kotelnicka, O., Margulska, A., & Strzelecki, D. (2023) · Metabolites · doi:10.3390/metabo13020182 · Cited by 11
“Recent studies, including meta-analytical summaries, emphasized the beneficial role of probiotic supplementation in reducing depressive symptoms when administered as an add-on [66].”
The researcher's guide to selecting biomarkers in mental health studies
Verhoeven, J. E., Wolkowitz, O. M., Satz, I. B., Conklin, Q. A., Lamers, F., Lavebratt, C., Lin, J., Lindqvist, D., Mayer, S. E., Melas, P. A., et al. (2024) · BioEssays · doi:10.1002/bies.202300246 · Cited by 12
“[133] Given the potential anti-inflammatory effect of probiotics, it is possible that this intervention is more efficacious in a subgroup of depressed patients with systemic low-grade inflammation.”
Vinpocetine attenuates fluoxetine-induced liver damage in rats; Role of Nrf2 and PPAR-γ
Kamel, G. A. M. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211051597 · Cited by 9
Gawlik-Kotelnicka, O., Burzyński, J., Rogalski, J. K., Skowrońska, A., & Strzelecki, D. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.07.1024 · Cited by 9
Rana, A., & Smriti (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70275 · Cited by 7
Cheng, Q., Ran, Y., Mo, X., Xiao, R., He, D., Guo, S., Wang, H., Liu, L., & Xie, P. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.05.004 · Cited by 10
Probiotics as technological innovations in psychiatric disorders: patents and research reviews
de Lima, A. A., Santos, S. S., de Araújo, M. A., Vinderola, G., Villarreal, C. F., & Viana, M. D. M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1567097 · Cited by 10
“Based on this, systematic review studies with meta-analysis have supported the hypothesis that probiotics can reduce depressive and anxiety symptoms through the modulation of neurotransmitters, suggesting the therapeutic potential of microorganisms (53–56).”
Filho, A. S. S., Souza, T. B., Martins, J. L. R., Dietz, G. P. H., Fernandes, K. F., de Sá, S., Inácio, P. A., Oliveira-Silva, I., Pedrino, G. R., Aprigliano, V., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19010156 · Cited by 7
“Strikingly, eleven studies were rated as low confidence (35.4%), reflecting recurrent deficits across multiple AMSTAR2-critical domains [32,34–36 ,40 ,41 Finally, four reviews (12.9”
InfluentialYu, B., Zhao, W.-W., Tao, L., & Li, K. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1800520 · Cited by 8
“From a therapeutic perspective, Nikolova et al. (2021) demonstrated that probiotic interventions can improve kynurenine metabolite balance through anti-inflammatory eects, providing a theoretical basis and practical pathways for improving tryptophan metabolism and improving neuropsychiatric…”
InfluentialFredj, S. B., Kechiche, H., Chouchen, A., Akkari, I., Ghammam, R., Zammit, N., douss, N., Skhiri, A., Maoua, M., Maatoug, J., et al. (2026) · BMC Psychology · doi:10.1186/s40359-025-03885-5 · Cited by 5
“Heterogeneity in intervention duration, ranging from 4 to 16 weeks, may have also contributed to the inconsistency in effect size across the included studies [81].”
Jijón, A. A. B., García, M. A., & Arias, R. T. (2024) · Revista San Gregorio · doi:10.36097/rsan.v1i58.2756 · Cited by 8
The Role of the Gut Microbiome in Bipolar Disorder and its Common Medical Comorbidities
Jones, G. H., Pinjari, O. F., Vecera, C. M., Smith, K., Barrera, A., & Machado‐Vieira, R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101078 · Cited by 5
Alzubide, S. R., & Alhalafi, M. (2024) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2024.143008 · Cited by 7
Gawlik-Kotelnicka, O., Sobczak, M., Palma, J., Popławska, M., Skonieczna-Żydecka, K., Plewka, M., Pawliczak, R., & Strzelecki, D. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.035 · Cited by 4
“Importantly, probiotics appear to exert their antidepressant effects primarily as an add-on treatment alongside antidepressants [27].”
Efficacy of Probiotics, Prebiotics, and Symbiotics for the Treatment of Depression: A meta-review
Morán, A. C. A., Castañeda, C. D. D. L., Rodríguez-Orozco, A. R., Oba, E. R. V., Loeza, B. M. L., & Villalobos, G. G. (2025) · Salud Mental · doi:10.17711/sm.0185-3325.2025.005 · Cited by 5
“Two reviews evaluated probiotic efficacy in monotherapy (Lin et al., 2023; Nikolova et al., 2021) yet reported no statistically significant differences compared to the placebo in their meta-analyses.”
InfluentialSaúde mental em perspetiva – o papel da nutrição e da microbiota intestinal
Charneca, S., & Guerreiro, C. S. (2021) · Acta Portuguesa de Nutrição · doi:10.21011/apn.2021.2710 · Cited by 11
“Nesta temática, os resultados de uma revisão sistemática e meta-análise sobre o efeito dos probióticos no tratamento da depressão indicam que estes são eficientes na redução os sintomas desta doença apenas quando administrados em conjunto com a medicação antidepressiva (61).”
BackgroundSinimeri, D., Childs, C. E., & Golm, D. (2025) · Nutrition Bulletin · doi:10.1111/nbu.12734 · Cited by 4
“There is a growing body of evidence linking depression to gastrointestinal (GI) or gut health (Nikolova, Cleare, et al. 2021; Nikolova, Hall et al. 2021).”
Bahji, A., Brietzke, E. M., Cooke, N. C. A., Clement, F. M., Frey, B. N., Hofmeister, M., Kennedy, S. H., Lam, R. W. M., Milev, R. V., Moinul, D., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251394363 · Cited by 5
Lindahl, J., Veibäck, G. S., Suneson, K., Blanking, W., Tjernberg, J., Ståhl, D., Wiman, Å., Ventorp, F., Erhardt, S., & Lindqvist, D. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101221 · Cited by 3
“A meta-analysis by Nikolova et al. indicated that probiotics are effective when used as an adjunctive, but not as a standalone, treatment (Nikolova et al., 2021).”
Wu, T., Xing, H., Wu, T., Xie, X., Ji, L., Wang, W., Zhang, X., Zhang, Y., Jiang, C., & Bao, T. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s591429 · Cited by 3
“101 These discrepancies underscore the importance of strain specificity, the sensitivity and comparability of outcome measures, and baseline microbiome composition in predicting treatment response.”
Zhao, H., Ao, L., Hao, L., Wei, Y., Yin, H. Z., Lee, X. Q., Guo, C., Zhenyi, W., Yang, J., Yang, R., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1848918 · Cited by 6
“A limited number of mechanistic studies have also observed increased serum BDNF levels or reduced KYN/TRP ratios, providing preliminary clinical support for the hypothesis that the microbiota may in fl u-ence depressive symptoms by modulating neurotransmitter – neuroplasticity pathways (63, 64).”
Schneider, A. E., Zeiler, M. D., Kopp, K., Wagner, G., & Karwautz, A. F. K. (2023) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000930 · Cited by 3
Johnson, D., Ramachandram, D. S., Doorly, J., Clarke, G. A., Chan, K., Thurairajasingam, S., Lee, L.-H., & Letchumanan, V. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251397332 · Cited by 3
“Numerous systematic reviews and meta-analyses have further supported the clinical use of probiotics as an adjunct to antidepressants (Alli et al., 2022; Goh et al., 2019; Huang et al., 2016; Lin et al., 2023; Musazadeh et al., 2022; Ng et al., 2023; Nikolova et al., 2019, 2021).”
Kamel, G. A. M., Harahsheh, E., & Hussein, S. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-022-03369-7 · Cited by 2
Sanmith, T. D., Paliwal, A., & bagul, K. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/9500368 · Cited by 2
Probiotics – when and for whom in the oncological patient population
Łoniewski, I., Kaźmierczak-Siedlecka, K., Komorniak, N., & Stachowska, E. (2024) · Nowotwory Journal of Oncology · doi:10.5603/njo.97333 · Cited by 2
Why nurturing the gut microbiota could resolve depression and anxiety
Makin, S. J. (2025) · Nature · doi:10.1038/d41586-025-02633-4 · Cited by 2
Uso de los probióticos como tratamiento de síntomas intestinales causados por depresión
Hernández, J. P. C., & Calle, D. F. C. (2023) · LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades · doi:10.56712/latam.v4i2.617 · Cited by 2
Gut microbiota: a perspective for bipolar disorders
Milani, P. G., Nazari, A., Fallahasgari, M., & Vadaei, S. (2024) · Gastrointestinal Nursing · doi:10.12968/gasn.2024.22.4.184 · Cited by 1
“Gut” to grips with the science of the microbiome – a symposium report
Finnegan, Y. E., Neill, H. R., Prpa, E. J., & Pot, B. (2024) · Gut Microbiome · doi:10.1017/gmb.2024.8 · Cited by 3
Dai, Q., Duan, Z., Fang, C., & Chen, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1735614 · Cited by 2
“Nevertheless, some evidence suggests that PP/S may offer a safer long-term alternative or adjunct to traditional laxatives, particularly for maintenance therapy (Nikolova et al., 2021; Mitelmao et al., 2022; Harris et al., 2025).”
Trkulja, V., & Barić, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_6 · Cited by 1
Zhou, J., Wang, X., Wang, R., Deng, Y., Lyu, N., Li, R., Li, X., Liu, J., Yang, J., Zhou, J. J., et al. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s534858 · Cited by 1
Amiri, D., Briziarelli, L., Shah, S. J., Karlsson, B., Amiri, S., Vakili, A. Z., & Mustakova, A. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101133 · Cited by 1
“…and activation of pathways such as the tryptophan – kynurenine metabolism, all of which have been implicated in mood and cognitive disorders (Ochoa-Rep ´ araz et al., 2018, Merchak and Gaultier, 2020, Chen et al., 2021, Nikolova et al., 2021, Nikolova et al., 2021, Generoso et al., 2021).”
Chen, Q., Guo, Z., Zhu, D., Wang, F., Sun, C., Li, R., Yin, D., Li, C., Xia, B., Li, W., et al. (2026) · Nutrients · doi:10.3390/nu18152468 · Cited by 1
“…the balance of the gut microbiota and exerting anti‑inflammatory ef‑ fects, partly through microbial metabolites such as short‑chain fatty acids [12,13]; meta‑ analyses of randomized controlled trials indicate that probiotic supplementation signif‑ icantly lowers depression scale scores [14,15].”
PROBİYOTİK MİKROORGANİZMALARIN SAĞLIK ÜZERİNE ETKİSİ
Aydın, İ., & Gulsunoglu‐Konuskan, Z. (2022) · Karya Journal of Health Science · doi:10.52831/kjhs.1100508 · Cited by 1
The importance of anti-inflammatory diet in depression: a literature review and recommendations
Wingralek, Z. J., Miś, P., Wróblewski, H., Zimna, A. I., & Róg, J. (2023) · Current Problems of Psychiatry · doi:10.12923/2353-8627/2023-0013 · Cited by 2
Kurinna, O. G., & Chernova, V. M. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-4-77 · Cited by 1
Knudsen, J. K. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau455013245
Latest advances in psychopharmacotherapy: what a pharmacist should know
Češková, E. (2023) · Farmacie pro praxi · doi:10.36290/lek.2023.002
The Benefits of Probiotics on Depression: A Systematic Mini-Review
Caruso, R., Rospigliosi, J. L. C., Checo, M., Investigaciones Biomedicas de Profamilia, S. D., de Oliveira, L. M. L., Farina, G. S., Fernandes, K. B. P., Jaldin-Pinto, A. V., Woite, N. L., Dominguez, A. M., et al. (2023) · Principles and Practice of Clinical Research Journal · doi:10.21801/ppcrj.2023.91.6
Zulfiqar, H., & Aslam, U. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.7782
Mota, A. S. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2024.tde-25042024-144356 · Cited by 1
Sanmith, T. D., Chourasiya, J., & Patel, N. (2024) · Archives of Medicine and Health Sciences · doi:10.4103/amhs.amhs_246_23 · Cited by 2
DO IMAGINÁRIO MONOLÍNGUE AO PLURILINGUISMO REAL
Bertozzo, A. F., & Krug, M. J. (2025) · doi:10.48209/978-65-5417-422-1
As TICs na educação: sugestões de plataformas para serem utilizadas nas aulas de matemática
PONTES, A. M., & SILVA, W. R. (2025) · doi:10.48209/978-65-5417-422-6
Melo, F., de Magalhães, V. A., & de Carvalho, V. C. A. (2025) · doi:10.48209/978-65-5417-422-b
A curricularização da extensão: fundamentos e políticas
PEREIRA, D. N. (2025) · doi:10.48209/978-65-5417-422-a
NINA, D. C., Sánchez, A. T., & Gironzini, M. M. A. (2025) · doi:10.48209/978-65-5417-422-4
Capuñay, J. E. C., & Vásquez, M. A. C. (2025) · doi:10.48209/978-65-5417-422-c
Metadata
- Authors
- Nikolova, V., Cleare, A., Young, A., & Stone, J.
- Affiliations
- King's College London (GB)
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Nikolova, Viktoriya
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-02-08
- Volume
- 10
- Issue
- 4
- Pages
- 647
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7915600
- OpenAlex
- W3126375840
- Cited by
- 106
- References
- 58
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 14 · 2023: 26 · 2022: 13 · 2021: 12
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0616-10091, NIHR202380)
- Medical Research Council (2171139)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, major depressive disorder, adjunctive therapy, antidepressants, gut microbiota, depressive symptoms, brain-derived neurotrophic factor, C-reactive protein, antidepressant efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.